For initial treatment of symptomatic pulmonary sarcoidosis, methotrexate appeared to work as well as prednisone over 24 weeks ...

Ten years after heading to Cannes with Alexander Payne's ‘Nebraska,' Squibb is back with ‘Eleanor the Great’ from director ...

Pfizer-backed CellCentric has secured $120 million in series C funds as the British biotech prepares to take its multiple ...

The revitalisation of GSK's blood cancer therapy Blenrep has continued with a second regulatory approval, in Japan, as a ...

With $27 billion earmarked to expand its U.S. production footprint starting this year, Eli Lilly is busy scouting out ...

A federal district court ruled in favor of the Health Resources and Services Administration, but raised questions about ...

Shares of Prime Medicine, Inc. (NASDAQ:PRME) fell 19.2% following the company’s announcement of a strategic restructuring ...

Century Therapeutics, Inc. (NASDAQ: IPSC) reported notable progress in Q1 2025, emphasizing advancements in its clinical and preclinical iPSC-derived cell therapy programs. Highlights include updates ...

Eleven-year follow-up data continue to show the invasive disease-free survival benefit for node-positive patients seen in previous analyses.